E-LIB Suche - Ergebnisse für: Thomson, Blythe

1

ACTR-52. PHASE 1 STUDY OF FT-2102, AN INHIBITOR OF MUTANT I..:

De la Fuente, Macarena I ; Colman, Howard ; Rosenthal, Mark...
Neuro-Oncology. 21 (2019) Supplement_6 - p. vi25-vi25 , 2019

Link: https://doi.org/10.1093/..

2

SCIDOT-42. FT-2102 – A POTENT AND SELECTIVE BRAIN PENETRANT..:

Ribadeneira, Maria ; Guichard, Sylvie ; Yao, Lili...
Neuro-Oncology. 21 (2019) Supplement_6 - p. vi280-vi280 , 2019

Link: https://doi.org/10.1093/..

3

Sorafenib treatment following hematopoietic stem cell trans..:

Tarlock, Katherine ; Chang, Bill ; Cooper, Todd...
Pediatric Blood & Cancer. 62 (2015) 6 - p. 1048-1054 , 2015

Link: https://doi.org/10.1002/..

4

Substitution with doxorubicin for daunorubicin during induc..:

Gardner, Rebecca A. ; Thomson, Blythe ; Hawkins, Douglas S.
Pediatric Blood & Cancer. 60 (2012) 2 - p. 338-339 , 2012

Link: https://doi.org/10.1002/..

5

Pure Erythroid Leukemia Following Precursor B-Cell Lymphobl..:

Xu, Min ; Finn, Laura S. ; Tsuchiya, Karen D....
Pediatric and Developmental Pathology. 15 (2012) 1 - p. 76-78 , 2012

Link: https://doi.org/10.2350/..

6

Minimal residual disease detected prior to hematopoietic ce..:

Foster, Jennifer H. ; Hawkins, Douglas S. ; Loken, Michael R...
Pediatric Blood & Cancer. 57 (2011) 1 - p. 163-165 , 2011

Link: https://doi.org/10.1002/..

7

Anti–interleukin-5 (mepolizumab) therapy for hypereosinophi..:

Garrett, Jennifer K ; Jameson, Sean C ; Thomson, Blythe...
Journal of Allergy and Clinical Immunology. 113 (2004) 1 - p. 115-119 , 2004

Link: https://doi.org/10.1016/..

8

Toxicity and efficacy of intensive chemotherapy for childre..:

Thomson, Blythe ; Park, Julie R. ; Felgenhauer, Judy...
Pediatric Blood & Cancer. 43 (2004) 5 - p. 571-579 , 2004

Link: https://doi.org/10.1002/..

9

Peripheral blood stem cell support reduces the toxicity of ..:

Hawkins, Douglas S. ; Felgenhauer, Judy ; Park, Julie...
Cancer. 95 (2002) 6 - p. 1354-1365 , 2002

Link: https://doi.org/10.1002/..

10

Advances in the detection of minimal residual disease:

Radich, Jerry ; Thomson, Blythe
Current Opinion in Hematology. 4 (1997) 4 - p. 242-247 , 1997

Link: https://doi.org/10.1097/..

11

Umbilical Cord Blood Collection, Banking, and Transplantati..:

Smith, Franklin O ; Thomson, Blythe G
Birth. 27 (2000) 2 - p. 127-135 , 2000

Link: https://doi.org/10.1046/..

12

Umbilical cord blood transplantation:

Smith, Franklin O. ; Thomson, Blythe G. ; Broxmeyer, Hal E.
Current Opinion in Organ Transplantation. 5 (2000) 4 - p. 358-365 , 2000

Link: https://doi.org/10.1097/..

13

The DOT1L inhibitor pinometostat reduces H3K79 methylation ..:

Stein, Eytan M ; Garcia-Manero, Guillermo ; Rizzieri, David A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265654/. , 2018

Link: http://www.ncbi.nlm.nih...

14

Escalating intravenous methotrexate improves event-free sur..:

Matloub, Yousif ; Bostrom, Bruce C ; Hunger, Stephen P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138679. , 2011

Link: http://www.ncbi.nlm.nih...

15

Phase 2 trial of clofarabine in combination with etoposide ..:

Hijiya, Nobuko ; Thomson, Blythe ; Isakoff, Michael S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731655. , 2011

Link: http://www.ncbi.nlm.nih...